Subscribe Free
in Maintenance

Dnata awarded UK MHRA certification for Good Distribution Practice

Posted 19 April 2018 · Add Comment

Global air services provider and UK’s leading ground handler, Dnata, has been awarded certification for Good Distribution Practice (GDP) by the UK Medicines and Healthcare Products Regulatory Agency (UK MHRA).

 

The UK MHRA granted Dnata full Wholesaler Dealer Authorisation (WDA) after Dnata completed the organisation’s Good Distribution Programme, while simultaneously investing into cutting-edge pharma handling technology at several of its facilities.

Dnata’s investment includes a sophisticated 24-hour warehouse monitoring system that has the ability to conduct temperature mapping and advise Dnata operators ahead of any deviation in temperature. This, in, turn enables pre-planning, quick response to adapt to adverse weather conditions and assessment of potential transport routes for pharma products.

Temperature mapping is also routinely conducted within Dnata’s facilities in the summer and winter to gauge average temperatures.

This leading-edge technology recently paid dividends when the cold front struck in early March and temperatures across the UK plummeted. Dnata was able to prepare for the severe temperature onslaught, and ensure that all pharmaceuticals handled followed the optimum route, at temperatures that limited the risk of spoilage.

In addition, the company has installed automated handling systems that can store pharmaceuticals at variable temperature ranges.

In order to achieve certification, Dnata was required to either review or make enhancements to its quality systems, operations documentation and facilities management practices – a 12 to 24-month process that it completed in just six months.

“We have invested in pharma-handling facilities across the UK in response to customer demand and in recognition of the growing importance of pharma cold-chain logistics,” said Dnata UK CEO Gary Morgan. 

“With world-class technology already in place at our facilities, the next logical step was to ensure standards compliance and achieve UK MHRA certification.  These initiatives not only demonstrate our ongoing focus on safety and quality, but also reinforce our commitment to our airline customers who operate in the fast-growing pharmaceutical transportation sector. ”

 

* required field

Post a comment

Other Stories
Advertisement
Latest News

Pegasus Airlines signs codeshare agreement with Nile Air

Turkey’s leading low-cost airline Pegasus has signed a codeshare agreement with Nile Air, Egypt’s largest private airline.

The hot spot

In-flight connectivity has the potential to unlock a $5.2 billion market within the Middle East region by 2035, according to a new report from the London School of Economics. Steve Nichols reports.

Aer Lingus orders A330 Cabin Service Trainer from Spatial

Following Spatial’s successful completion of upgrade works to Aer Lingus’s A320 Cabin Emergency Evacuation Trainer and A330 Door Trainer in 2017, Spatial has been appointed to manufacture an A330 Cabin Service Trainer.

Etihad sees more losses for 2017 but reports positive signs of turnaround

The depth of Etihad Airways continuing disappointing financial performance was made clearer today with a partial disclosure of its 2017 figures.

Honeywell and Flightaware to enhance flight-tracking capabilities

Honeywell is joining forces with flight tracking data company FlightAwar to bring a new level of advanced flight tracking support to operations control centres and business jet owners.

Vallair leases three Airbus A321s to Onur Air in Turkey

Vallair, the aircraft trading, leasing and specialist MRO organisation has completed lease transactions for three Airbus A321 aircraft with Onur Air in Turkey.

TAA SK0902311218
See us at
ASDubai BT1004091018Cargo BT1004091018Istanbul Airshow BT22018AIME19BTA3005120219BIAS BT271017161118GATM BT1004061118MEBAA BT1004121218